• Skip to main content
  • Skip to primary sidebar
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News

CBD OIL

Cannabis Consumption Lounges Set to Hit Nevada Next Year

August 31, 2021 by CBD OIL

Missouri did not launch medical cannabis sales until Oct. 16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access.

The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. 6, 2019, and Dec. 5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program.

The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. That year, Missouri home cultivators were comprised of 7,276 patients and 298 caregivers.

But with the state’s first medical cannabis sales launching this past October, the number of approved patients grew by roughly 200% during 2020. In addition, approved caregivers grew from 563 to 2,146, and home cultivators grew from 7,574 to 19,831.

DHSS is required by law to annually submit a report to the governor regarding the efficient discharge of its responsibilities.

“It is an honor to be a part of the great success of this new medical industry in Missouri,” Lyndall Fraker, director of the section of medical cannabis within the DHSS, said in a news release Aug. 19, when the second annual report was published.

“I continue to be amazed at how hard our team is working in order to help our facilities provide this alternative medicine for the state’s fast growing patient base,” he said. “Our goal is to provide a safe, well-regulated and patient-focused program second to none in our great nation. Our success undeniably proves we have accomplished this goal in a timely manner, meeting all of our constitutional obligations as decided by the citizens of the great state of Missouri.”

Sixty-five percent of Missouri voters passed Amendment 2 to legalize medical cannabis during the November 2018 election. A month later, it was added to the Missouri Constitution, granting the DHSS the authority and responsibility to create a well-regulated program to ensure the availability of, and safe access to, medical cannabis.

Including Missouri, 21 states implemented medical cannabis laws since 2005, according to DHSS. While the national average for implementation is 29 months, Missouri implemented its program in just over 23 months. Only five states implemented programs faster: Pennsylvania (22), New York (18), Utah (16), Minnesota (13) and Oklahoma (4), according to DHSS.

The quickest state in the nation to implement an effective medical cannabis program, Oklahoma had roughly 376,000 registered patients as of earlier this month. Voters there approved State Question 788 to legalized medical cannabis on June 26, 2018.

Missouri, by comparison, had 69,387 registered patients as of December 2020. Among those patients, the most common qualifying medical condition listed was a physical or psychological dependence on another drug, with 20,988 individuals checking that box.

Meanwhile, 17,492 patients with non-defined chronic medical conditions were the second most common. Psychiatric disorders accounted for 11,914 patients. Migraines accounted for 3,843 patients. And those suffering from terminal illnesses, such as cancer, represented 2,304 of the qualifying patients.

Those aged 30 to 39 years represented 24.7% of the patients, while 40 to 49 years (20.2%), 50 to 59 years (18%), 60 to 69 years (16.9%), 18 to 29 years (15.1%) and those 70 years and older (4.7%) followed suit. Those 17 and under accounted for 0.3% of patients.

Beginning in December 2019, DHSS issued licenses to all types of medical cannabis facilities after reviewing more than 2,000 applications. As of December 2020, 192 dispensary licenses were issued, as well as licenses for 86 manufacturing and 60 cultivation facilities. However, as of December 2020, only 17 dispensaries, one manufacturer and 10 cultivation facilities had completed a DHSS Commencement Inspection and been given the final approval to operate.

The 192 dispensary licenses allowed in Missouri represent approximately 3.1 dispensaries per 100,000 population in the state, which is third only to Oklahoma (51.8 dispensaries per 100,000) and New Mexico (5.2 dispensaries per 100,000) among the 21 states that have implemented programs since 2005, according to DHSS data compiled from August 2020. Both Oklahoma, which was up to 2,325 dispensaries as of earlier this month, and New Mexico have unlimited licensing systems.

In the current and upcoming program years, DHSS will continue to monitor facilities’ progress and ability to meet the needs of patients, according to the news release.

“We will continue to pursue public engagement and transparency, which has always been a key component of this program’s success, and further develop consistent regulation, enforcement and education in order to ensure it is successful in providing safe and secure access to medical marijuana for qualifying Missouri patients,” Fraker said.

Filed Under: Cannabis News

Mississippi Agriculture Commissioner Does Not Want Medical Cannabis Regulated Under His Department

August 31, 2021 by CBD OIL

Missouri did not launch medical cannabis sales until Oct. 16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access.

The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. 6, 2019, and Dec. 5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program.

The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. That year, Missouri home cultivators were comprised of 7,276 patients and 298 caregivers.

But with the state’s first medical cannabis sales launching this past October, the number of approved patients grew by roughly 200% during 2020. In addition, approved caregivers grew from 563 to 2,146, and home cultivators grew from 7,574 to 19,831.

DHSS is required by law to annually submit a report to the governor regarding the efficient discharge of its responsibilities.

“It is an honor to be a part of the great success of this new medical industry in Missouri,” Lyndall Fraker, director of the section of medical cannabis within the DHSS, said in a news release Aug. 19, when the second annual report was published.

“I continue to be amazed at how hard our team is working in order to help our facilities provide this alternative medicine for the state’s fast growing patient base,” he said. “Our goal is to provide a safe, well-regulated and patient-focused program second to none in our great nation. Our success undeniably proves we have accomplished this goal in a timely manner, meeting all of our constitutional obligations as decided by the citizens of the great state of Missouri.”

Sixty-five percent of Missouri voters passed Amendment 2 to legalize medical cannabis during the November 2018 election. A month later, it was added to the Missouri Constitution, granting the DHSS the authority and responsibility to create a well-regulated program to ensure the availability of, and safe access to, medical cannabis.

Including Missouri, 21 states implemented medical cannabis laws since 2005, according to DHSS. While the national average for implementation is 29 months, Missouri implemented its program in just over 23 months. Only five states implemented programs faster: Pennsylvania (22), New York (18), Utah (16), Minnesota (13) and Oklahoma (4), according to DHSS.

The quickest state in the nation to implement an effective medical cannabis program, Oklahoma had roughly 376,000 registered patients as of earlier this month. Voters there approved State Question 788 to legalized medical cannabis on June 26, 2018.

Missouri, by comparison, had 69,387 registered patients as of December 2020. Among those patients, the most common qualifying medical condition listed was a physical or psychological dependence on another drug, with 20,988 individuals checking that box.

Meanwhile, 17,492 patients with non-defined chronic medical conditions were the second most common. Psychiatric disorders accounted for 11,914 patients. Migraines accounted for 3,843 patients. And those suffering from terminal illnesses, such as cancer, represented 2,304 of the qualifying patients.

Those aged 30 to 39 years represented 24.7% of the patients, while 40 to 49 years (20.2%), 50 to 59 years (18%), 60 to 69 years (16.9%), 18 to 29 years (15.1%) and those 70 years and older (4.7%) followed suit. Those 17 and under accounted for 0.3% of patients.

Beginning in December 2019, DHSS issued licenses to all types of medical cannabis facilities after reviewing more than 2,000 applications. As of December 2020, 192 dispensary licenses were issued, as well as licenses for 86 manufacturing and 60 cultivation facilities. However, as of December 2020, only 17 dispensaries, one manufacturer and 10 cultivation facilities had completed a DHSS Commencement Inspection and been given the final approval to operate.

The 192 dispensary licenses allowed in Missouri represent approximately 3.1 dispensaries per 100,000 population in the state, which is third only to Oklahoma (51.8 dispensaries per 100,000) and New Mexico (5.2 dispensaries per 100,000) among the 21 states that have implemented programs since 2005, according to DHSS data compiled from August 2020. Both Oklahoma, which was up to 2,325 dispensaries as of earlier this month, and New Mexico have unlimited licensing systems.

In the current and upcoming program years, DHSS will continue to monitor facilities’ progress and ability to meet the needs of patients, according to the news release.

“We will continue to pursue public engagement and transparency, which has always been a key component of this program’s success, and further develop consistent regulation, enforcement and education in order to ensure it is successful in providing safe and secure access to medical marijuana for qualifying Missouri patients,” Fraker said.

Filed Under: Cannabis News

Missouri Medical Cannabis Program Adds Some 56,000 New Patients in Second Year

August 31, 2021 by CBD OIL

Missouri did not launch medical cannabis sales until Oct. 16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access.

The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. 6, 2019, and Dec. 5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program.

The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate. That year, Missouri home cultivators were comprised of 7,276 patients and 298 caregivers.

But with the state’s first medical cannabis sales launching this past October, the number of approved patients grew by roughly 200% during 2020. In addition, approved caregivers grew from 563 to 2,146, and home cultivators grew from 7,574 to 19,831.

DHSS is required by law to annually submit a report to the governor regarding the efficient discharge of its responsibilities.

“It is an honor to be a part of the great success of this new medical industry in Missouri,” Lyndall Fraker, director of the section of medical cannabis within the DHSS, said in a news release Aug. 19, when the second annual report was published.

“I continue to be amazed at how hard our team is working in order to help our facilities provide this alternative medicine for the state’s fast growing patient base,” he said. “Our goal is to provide a safe, well-regulated and patient-focused program second to none in our great nation. Our success undeniably proves we have accomplished this goal in a timely manner, meeting all of our constitutional obligations as decided by the citizens of the great state of Missouri.”

Sixty-five percent of Missouri voters passed Amendment 2 to legalize medical cannabis during the November 2018 election. A month later, it was added to the Missouri Constitution, granting the DHSS the authority and responsibility to create a well-regulated program to ensure the availability of, and safe access to, medical cannabis.

Including Missouri, 21 states implemented medical cannabis laws since 2005, according to DHSS. While the national average for implementation is 29 months, Missouri implemented its program in just over 23 months. Only five states implemented programs faster: Pennsylvania (22), New York (18), Utah (16), Minnesota (13) and Oklahoma (4), according to DHSS.

The quickest state in the nation to implement an effective medical cannabis program, Oklahoma had roughly 376,000 registered patients as of earlier this month. Voters there approved State Question 788 to legalized medical cannabis on June 26, 2018.

Missouri, by comparison, had 69,387 registered patients as of December 2020. Among those patients, the most common qualifying medical condition listed was a physical or psychological dependence on another drug, with 20,988 individuals checking that box.

Meanwhile, 17,492 patients with non-defined chronic medical conditions were the second most common. Psychiatric disorders accounted for 11,914 patients. Migraines accounted for 3,843 patients. And those suffering from terminal illnesses, such as cancer, represented 2,304 of the qualifying patients.

Those aged 30 to 39 years represented 24.7% of the patients, while 40 to 49 years (20.2%), 50 to 59 years (18%), 60 to 69 years (16.9%), 18 to 29 years (15.1%) and those 70 years and older (4.7%) followed suit. Those 17 and under accounted for 0.3% of patients.

Beginning in December 2019, DHSS issued licenses to all types of medical cannabis facilities after reviewing more than 2,000 applications. As of December 2020, 192 dispensary licenses were issued, as well as licenses for 86 manufacturing and 60 cultivation facilities. However, as of December 2020, only 17 dispensaries, one manufacturer and 10 cultivation facilities had completed a DHSS Commencement Inspection and been given the final approval to operate.

The 192 dispensary licenses allowed in Missouri represent approximately 3.1 dispensaries per 100,000 population in the state, which is third only to Oklahoma (51.8 dispensaries per 100,000) and New Mexico (5.2 dispensaries per 100,000) among the 21 states that have implemented programs since 2005, according to DHSS data compiled from August 2020. Both Oklahoma, which was up to 2,325 dispensaries as of earlier this month, and New Mexico have unlimited licensing systems.

In the current and upcoming program years, DHSS will continue to monitor facilities’ progress and ability to meet the needs of patients, according to the news release.

“We will continue to pursue public engagement and transparency, which has always been a key component of this program’s success, and further develop consistent regulation, enforcement and education in order to ensure it is successful in providing safe and secure access to medical marijuana for qualifying Missouri patients,” Fraker said.

Filed Under: Cannabis News

Ohio Ballot Board Certifies Coalition to Regulate Marijuana Like Alcohol’s Initiative as Single Issue

August 30, 2021 by CBD OIL

Kind Idaho Chair Jackee Winters is laser-focused on qualifying the group’s medical cannabis legalization initiative for the state’s 2022 ballot in order to help her daughter, who suffers from a brain tumor, get legal access to cannabis.

“It’s time for Idaho to grow up,” she told Cannabis Business Times and Cannabis Dispensary. “There are people here who suffer, and we’re behind the times. We need medical advancements in Idaho, and I don’t want to have to relocate my entire family. … It’s not fair that she’s got to suffer, and they basically try to turn us all into criminals by not letting us have our own choice.”

Winters said Kind Idaho has a “skeleton crew” of volunteers in different parts of the state, and has collected roughly 5,000 of the 65,000 total signatures needed to get the group’s medical cannabis legalization measure, the Idaho Medical Marijuana Act for 2022 (IMMA), before voters next year.

IMMA would legalize the possession of up to 4 ounces of cannabis for medical purposes, as well as the home cultivation of up to six plants for patients with a “hardship waiver.” The measure would also create a system of dispensaries to sell medical cannabis to qualified patients in the state.

“We’re asking for regulated medication—cannabis—that would be available to [patients] when they need it,” Winters said. “We really need something … for the people in Idaho who suffer.”

Recruiting volunteers has been challenging, Winters said, and speculated that people simply may not be familiar with the Kind Idaho campaign.

“People may not know of us because it’s our first time doing this, or [word] hasn’t gotten out there,” she said.

Kind Idaho just finished a push to gather signatures at Hempfest, an educational event held Aug. 14 in Boise, and plans to send volunteers to upcoming fairs in the state.

“We just keep trucking along, wishing for the best,” Winters said.

The Idaho Way, formerly known as the Idaho Citizen Coalition for Cannabis, is also working to bring cannabis policy reform to Idaho in the form of a decriminalization initiative called the Personal Adult Marijuana Decriminalization Act (PAMDA).

PAMDA would not create a commercial adult-use cannabis industry in Idaho, but would legalize the personal possession of up to 3 ounces of cannabis in private for adults 21 and older.

Like Kind Idaho, The Idaho Way is currently in the process of collecting roughly 65,000 signatures to place PAMDA on Idaho’s 2022 ballot.

RELATED: Idaho Cannabis Advocates Launch Legalization Efforts in ‘The Most Hostile State’ Toward Policy Reform

During its last legislative session, the Idaho Legislature passed S.B. 1110, which changed the signature-gathering requirements for groups like Kind Idaho and The Idaho Way to get their measures before voters.

Under Idaho’s previous law, which went into effect in 2013, campaigns had to collect signatures from 6% of the registered voters in 18 of Idaho’s 35 legislative districts. Under S.B. 1110, they must gather signatures from 6% of registered voters in all 35 districts to qualify their initiatives for the ballot, which Winters said is “virtually impossible.”

Kind Idaho submitted IMMA before the new law took effect, allowing the campaign to qualify its initiative with signatures from 18 of the state’s districts, while The Idaho Way had to operate under the new law and gather signatures from all 35 districts.

Reclaim Idaho, a campaign behind a ballot initiative for Medicaid expansion, sued over S.B. 1110 in May, and the Idaho Supreme Court ruled Aug. 23 that the new law is unconstitutional, according to an Idaho Statesman report.

In its ruling, the Supreme Court said the law infringed on the public’s right to enact laws outside of the Legislature, and that both the Legislature and the Secretary of State’s Office “failed to present a compelling state interest for limiting that right,” the news outlet reported.

Kind Idaho and The Idaho Way were both watching the case closely.

“Should the decision go in Reclaim’s favor, and the law returns with the 18-district threshold, then we’ll be moving forward with our PAMDA initiative,” Russ Belville, a spokesman for The Idaho Way, told Cannabis Business Times and Cannabis Dispensary earlier this month. “If it doesn’t go in our favor and we’re stuck with 35 districts, we’ll probably fold the PAMDA initiative and put all our efforts into the IMMA medical initiative.”

Winters said Belville had been helping the Kind Idaho campaign prior to launching the PAMDA initiative, and the two groups are continuing to work together as much as possible.

“Everyone working together is how we’re going to get this done,” she said, adding that she is gathering signatures alongside Kind Idaho’s volunteers. “I’m actually out there in my community getting signatures because it’s very important to Idaho and I want to be part of this changing of times, making history in Idaho.”

Filed Under: Cannabis News

Delaware Lawmaker Will Reintroduce Cannabis Legalization Bill in January

August 30, 2021 by CBD OIL

Kind Idaho Chair Jackee Winters is laser-focused on qualifying the group’s medical cannabis legalization initiative for the state’s 2022 ballot in order to help her daughter, who suffers from a brain tumor, get legal access to cannabis.

“It’s time for Idaho to grow up,” she told Cannabis Business Times and Cannabis Dispensary. “There are people here who suffer, and we’re behind the times. We need medical advancements in Idaho, and I don’t want to have to relocate my entire family. … It’s not fair that she’s got to suffer, and they basically try to turn us all into criminals by not letting us have our own choice.”

Winters said Kind Idaho has a “skeleton crew” of volunteers in different parts of the state, and has collected roughly 5,000 of the 65,000 total signatures needed to get the group’s medical cannabis legalization measure, the Idaho Medical Marijuana Act for 2022 (IMMA), before voters next year.

IMMA would legalize the possession of up to 4 ounces of cannabis for medical purposes, as well as the home cultivation of up to six plants for patients with a “hardship waiver.” The measure would also create a system of dispensaries to sell medical cannabis to qualified patients in the state.

“We’re asking for regulated medication—cannabis—that would be available to [patients] when they need it,” Winters said. “We really need something … for the people in Idaho who suffer.”

Recruiting volunteers has been challenging, Winters said, and speculated that people simply may not be familiar with the Kind Idaho campaign.

“People may not know of us because it’s our first time doing this, or [word] hasn’t gotten out there,” she said.

Kind Idaho just finished a push to gather signatures at Hempfest, an educational event held Aug. 14 in Boise, and plans to send volunteers to upcoming fairs in the state.

“We just keep trucking along, wishing for the best,” Winters said.

The Idaho Way, formerly known as the Idaho Citizen Coalition for Cannabis, is also working to bring cannabis policy reform to Idaho in the form of a decriminalization initiative called the Personal Adult Marijuana Decriminalization Act (PAMDA).

PAMDA would not create a commercial adult-use cannabis industry in Idaho, but would legalize the personal possession of up to 3 ounces of cannabis in private for adults 21 and older.

Like Kind Idaho, The Idaho Way is currently in the process of collecting roughly 65,000 signatures to place PAMDA on Idaho’s 2022 ballot.

RELATED: Idaho Cannabis Advocates Launch Legalization Efforts in ‘The Most Hostile State’ Toward Policy Reform

During its last legislative session, the Idaho Legislature passed S.B. 1110, which changed the signature-gathering requirements for groups like Kind Idaho and The Idaho Way to get their measures before voters.

Under Idaho’s previous law, which went into effect in 2013, campaigns had to collect signatures from 6% of the registered voters in 18 of Idaho’s 35 legislative districts. Under S.B. 1110, they must gather signatures from 6% of registered voters in all 35 districts to qualify their initiatives for the ballot, which Winters said is “virtually impossible.”

Kind Idaho submitted IMMA before the new law took effect, allowing the campaign to qualify its initiative with signatures from 18 of the state’s districts, while The Idaho Way had to operate under the new law and gather signatures from all 35 districts.

Reclaim Idaho, a campaign behind a ballot initiative for Medicaid expansion, sued over S.B. 1110 in May, and the Idaho Supreme Court ruled Aug. 23 that the new law is unconstitutional, according to an Idaho Statesman report.

In its ruling, the Supreme Court said the law infringed on the public’s right to enact laws outside of the Legislature, and that both the Legislature and the Secretary of State’s Office “failed to present a compelling state interest for limiting that right,” the news outlet reported.

Kind Idaho and The Idaho Way were both watching the case closely.

“Should the decision go in Reclaim’s favor, and the law returns with the 18-district threshold, then we’ll be moving forward with our PAMDA initiative,” Russ Belville, a spokesman for The Idaho Way, told Cannabis Business Times and Cannabis Dispensary earlier this month. “If it doesn’t go in our favor and we’re stuck with 35 districts, we’ll probably fold the PAMDA initiative and put all our efforts into the IMMA medical initiative.”

Winters said Belville had been helping the Kind Idaho campaign prior to launching the PAMDA initiative, and the two groups are continuing to work together as much as possible.

“Everyone working together is how we’re going to get this done,” she said, adding that she is gathering signatures alongside Kind Idaho’s volunteers. “I’m actually out there in my community getting signatures because it’s very important to Idaho and I want to be part of this changing of times, making history in Idaho.”

Filed Under: Cannabis News

Third Senate Committee Approves North Carolina Medical Cannabis Bill

August 30, 2021 by CBD OIL

Kind Idaho Chair Jackee Winters is laser-focused on qualifying the group’s medical cannabis legalization initiative for the state’s 2022 ballot in order to help her daughter, who suffers from a brain tumor, get legal access to cannabis.

“It’s time for Idaho to grow up,” she told Cannabis Business Times and Cannabis Dispensary. “There are people here who suffer, and we’re behind the times. We need medical advancements in Idaho, and I don’t want to have to relocate my entire family. … It’s not fair that she’s got to suffer, and they basically try to turn us all into criminals by not letting us have our own choice.”

Winters said Kind Idaho has a “skeleton crew” of volunteers in different parts of the state, and has collected roughly 5,000 of the 65,000 total signatures needed to get the group’s medical cannabis legalization measure, the Idaho Medical Marijuana Act for 2022 (IMMA), before voters next year.

IMMA would legalize the possession of up to 4 ounces of cannabis for medical purposes, as well as the home cultivation of up to six plants for patients with a “hardship waiver.” The measure would also create a system of dispensaries to sell medical cannabis to qualified patients in the state.

“We’re asking for regulated medication—cannabis—that would be available to [patients] when they need it,” Winters said. “We really need something … for the people in Idaho who suffer.”

Recruiting volunteers has been challenging, Winters said, and speculated that people simply may not be familiar with the Kind Idaho campaign.

“People may not know of us because it’s our first time doing this, or [word] hasn’t gotten out there,” she said.

Kind Idaho just finished a push to gather signatures at Hempfest, an educational event held Aug. 14 in Boise, and plans to send volunteers to upcoming fairs in the state.

“We just keep trucking along, wishing for the best,” Winters said.

The Idaho Way, formerly known as the Idaho Citizen Coalition for Cannabis, is also working to bring cannabis policy reform to Idaho in the form of a decriminalization initiative called the Personal Adult Marijuana Decriminalization Act (PAMDA).

PAMDA would not create a commercial adult-use cannabis industry in Idaho, but would legalize the personal possession of up to 3 ounces of cannabis in private for adults 21 and older.

Like Kind Idaho, The Idaho Way is currently in the process of collecting roughly 65,000 signatures to place PAMDA on Idaho’s 2022 ballot.

RELATED: Idaho Cannabis Advocates Launch Legalization Efforts in ‘The Most Hostile State’ Toward Policy Reform

During its last legislative session, the Idaho Legislature passed S.B. 1110, which changed the signature-gathering requirements for groups like Kind Idaho and The Idaho Way to get their measures before voters.

Under Idaho’s previous law, which went into effect in 2013, campaigns had to collect signatures from 6% of the registered voters in 18 of Idaho’s 35 legislative districts. Under S.B. 1110, they must gather signatures from 6% of registered voters in all 35 districts to qualify their initiatives for the ballot, which Winters said is “virtually impossible.”

Kind Idaho submitted IMMA before the new law took effect, allowing the campaign to qualify its initiative with signatures from 18 of the state’s districts, while The Idaho Way had to operate under the new law and gather signatures from all 35 districts.

Reclaim Idaho, a campaign behind a ballot initiative for Medicaid expansion, sued over S.B. 1110 in May, and the Idaho Supreme Court ruled Aug. 23 that the new law is unconstitutional, according to an Idaho Statesman report.

In its ruling, the Supreme Court said the law infringed on the public’s right to enact laws outside of the Legislature, and that both the Legislature and the Secretary of State’s Office “failed to present a compelling state interest for limiting that right,” the news outlet reported.

Kind Idaho and The Idaho Way were both watching the case closely.

“Should the decision go in Reclaim’s favor, and the law returns with the 18-district threshold, then we’ll be moving forward with our PAMDA initiative,” Russ Belville, a spokesman for The Idaho Way, told Cannabis Business Times and Cannabis Dispensary earlier this month. “If it doesn’t go in our favor and we’re stuck with 35 districts, we’ll probably fold the PAMDA initiative and put all our efforts into the IMMA medical initiative.”

Winters said Belville had been helping the Kind Idaho campaign prior to launching the PAMDA initiative, and the two groups are continuing to work together as much as possible.

“Everyone working together is how we’re going to get this done,” she said, adding that she is gathering signatures alongside Kind Idaho’s volunteers. “I’m actually out there in my community getting signatures because it’s very important to Idaho and I want to be part of this changing of times, making history in Idaho.”

Filed Under: Cannabis News

Lazarus Naturals – CBD Health and Wellness

August 30, 2021 by CBD OIL

https://www.lazarusnaturals.com

The new fast-acting, long-lasting muscle gel from Lazarus Naturals offers a double punch of pain relieving ingredients and highly effective full-spectrum CBD to relieve sore muscles and relieve tension through targeted support. While many solutions available can relieve pain for a feeling of instant relief, the quick-absorbing gel provides persistent breathing space. Active, functional ingredients like menthol and capsaicin put the baton on the CBD you know and trust to get the job done.

Lazarus Naturals strives to provide customers with effective, high quality CBD that is affordable for everyone. From growing our own organic hemp in central Oregon to the constantly growing product family, the focus is always on consistency and sustainability. As pioneers in the CBD industry, Lazarus Naturals has learned to do things right – and to pass this on to customers by keeping prices low and potency high.

The rounded one Product range contains oil tinctures, softgels and capsules, edibles, muscle gel, lotions and balms, massage oil and coconut oil as well as CBD for four-legged friends such as dog treats and specially formulated tinctures for pets.

Go through all products from Lazarus Naturals Third party testing on potency, pesticides and heavy metals to ensure quality and safety standards are met. All test results can be viewed on the individual product pages of the website by going to the “Test Results” tab and matching the batch number on the packaging.

Filed Under: CBD Health

CBD, natural products and The Divine Feminine

August 30, 2021 by CBD OIL

Cannabidiol (CBD) continues to be added to a wide variety of health and beauty products, including face creams, soaps, and makeup. More recently, however, the cannabinoid has also been found in feminine products. The question is, does CBD bring any benefit to women’s care? And is it safe at all?

CBD has been linked to several medicinal benefits, including relief from pain and inflammation. It’s no wonder more and more women are using CBD as a more natural alternative to pain relievers to help curb the discomfort they often experience during their menstrual cycles and after sex. Since inflammation is typically the source of pain and discomfort in the reproductive region, as a powerful natural anti-inflammatory agent, CBD may be able to effectively relieve discomfort in this area. [1]

Given that the vaginal area is extremely sensitive and easily affected by the introduction of certain products, it is easy to understand why certain questions about the safety and effectiveness of CBD infused women’s products such as tampons, vaginal suppositories, vaginal lubricants, etc.

However, some experts in the obstetrics and gynecology world believe that CBD could have a beneficial effect on symptoms associated with menstruation and even sex.

What we currently know about CBD is that it interacts with the endocannabinoid system receptors in the body to produce specific effects, such as: B. reducing pain, inflammation, anxiety, and others. [2] Since there are cannabinoid receptors in the vaginal mucosa, it stands to reason that the presence of CBD in this region could have local pain relieving effects as the cannabinoids work with the receptors in the vaginal wall.

A CBD product placed directly into the vaginal wall enables the cannabinoid to be absorbed directly into the blood vessels in the area and released into the bloodstream. This can work better than orally administered CBD, which has to pass through the digestive tract and liver before entering the bloodstream.

However, there are not yet many studies that prove the effects of CBD when used vaginally. More research is needed to confirm the use of CBD in this way, especially regarding the correct dosage and possible side effects. At the very least, CBD products cannot always serve as a substitute for traditional remedies, but can be a great addition to more conventional products.

Anyone looking to try a CBD-based product for use in the vaginal area should do a small patch test prior to generous use, similar to any other new product. In addition, feminine products with fragrances should be avoided.

Image source: Jill Wellington from Pixabay


References:

1- Nagarkatti, P, et al., “Cannabinoids as Novel Anti-Inflammatory Drugs,” Future Med Chem., October 2009, 1 (7): 1333-1349.

2- Zou, S. & Kimar, U., “Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System,” Int. J. Mol. Sci., Mar 2018, 19 (3): 833.

Filed Under: CBD Health

Good CBD Eats in the US and Where to Find It

August 30, 2021 by CBD OIL

The cannabidiol (CBD) craze is not over yet.

Actually interested in CBD products keep on climbing. You can now buy anything from CBD-infused lip gloss to a CBD pillows. However, the most popular CBD products could be edibles. Digesting CBD has a very different effect than smoking it or smearing it on your skin.

If you’re interested in nibbling on a CBD biscuit or sipping a cannabinoid latte, you’re in luck – there are tons of high quality CBD edibles for sale in the U.S. Here are a few tasty options:

1- Wyld raspberry CBD gum

West Coast cannabis lovers may recognize the brand. Wyld is a Portland based cannabis that makes some of the most delicious gums on the market. The raspberry gums are both sweet and strong as they are fortified with 500 mg of CBD.

2- CBD American shaman kettle popcorn

Who doesn’t love popcorn? It’s the ultimate snack food – crispy, salty, and slightly greasy. This bag of popcorn is fortified with 30 mg of CBD. That can be anything you need to eat to feel more relaxed and comfortable.

3- 502 Hemp CBD Infused Cookies

These are ooey, sticky chocolate chip cookies, thick with 25 mg of CBD. The cookies are also gluten-free, vegan and made in a special allergen-free facility. They’re a healthier alternative to traditional cookies that might be worth eating even if you’re not into CBD.

4- LuLus CBD chocolate

Tetrahydrocannabinol (THC) cannabis chocolate often has a recognizable taste, especially if you are not used to eating edibles. However, CBD chocolate usually tastes the same as regular chocolate. So it’s no wonder that this LuLu chocolate is creamy and rich. What makes it special is the high quality CBD that it is fortified with.

Where to Find CBD Edibles

Hemp CBD is legal in every state, so finding edibles online is easy. You don’t have to live in a state with a legal cannabis market. You can go straight to the manufacturer’s website or shop from a general CBD retailer.

If you live in a legal state it is worth going to a pharmacy. So you can be absolutely sure that you are purchasing a high quality product.

Image source: Pixabay

Filed Under: CBD Health

Kind Idaho Ramps Up Efforts to Place Medical Cannabis Legalization Initiative on State’s 2022 Ballot

August 26, 2021 by CBD OIL

Kind Idaho Chair Jackee Winters is laser-focused on qualifying the group’s medical cannabis legalization initiative for the state’s 2022 ballot in order to help her daughter, who suffers from a brain tumor, get legal access to cannabis.

“It’s time for Idaho to grow up,” she told Cannabis Business Times and Cannabis Dispensary. “There are people here who suffer, and we’re behind the times. We need medical advancements in Idaho, and I don’t want to have to relocate my entire family. … It’s not fair that she’s got to suffer, and they basically try to turn us all into criminals by not letting us have our own choice.”

Winters said Kind Idaho has a “skeleton crew” of volunteers in different parts of the state, and has collected roughly 5,000 of the 65,000 total signatures needed to get the group’s medical cannabis legalization measure, the Idaho Medical Marijuana Act for 2022 (IMMA), before voters next year.

IMMA would legalize the possession of up to 4 ounces of cannabis for medical purposes, as well as the home cultivation of up to six plants for patients with a “hardship waiver.” The measure would also create a system of dispensaries to sell medical cannabis to qualified patients in the state.

“We’re asking for regulated medication—cannabis—that would be available to [patients] when they need it,” Winters said. “We really need something … for the people in Idaho who suffer.”

Recruiting volunteers has been challenging, Winters said, and speculated that people simply may not be familiar with the Kind Idaho campaign.

“People may not know of us because it’s our first time doing this, or [word] hasn’t gotten out there,” she said.

Kind Idaho just finished a push to gather signatures at Hempfest, an educational event held Aug. 14 in Boise, and plans to send volunteers to upcoming fairs in the state.

“We just keep trucking along, wishing for the best,” Winters said.

The Idaho Way, formerly known as the Idaho Citizen Coalition for Cannabis, is also working to bring cannabis policy reform to Idaho in the form of a decriminalization initiative called the Personal Adult Marijuana Decriminalization Act (PAMDA).

PAMDA would not create a commercial adult-use cannabis industry in Idaho, but would legalize the personal possession of up to 3 ounces of cannabis in private for adults 21 and older.

Like Kind Idaho, The Idaho Way is currently in the process of collecting roughly 65,000 signatures to place PAMDA on Idaho’s 2022 ballot.

RELATED: Idaho Cannabis Advocates Launch Legalization Efforts in ‘The Most Hostile State’ Toward Policy Reform

During its last legislative session, the Idaho Legislature passed S.B. 1110, which changed the signature-gathering requirements for groups like Kind Idaho and The Idaho Way to get their measures before voters.

Under Idaho’s previous law, which went into effect in 2013, campaigns had to collect signatures from 6% of the registered voters in 18 of Idaho’s 35 legislative districts. Under S.B. 1110, they must gather signatures from 6% of registered voters in all 35 districts to qualify their initiatives for the ballot, which Winters said is “virtually impossible.”

Kind Idaho submitted IMMA before the new law took effect, allowing the campaign to qualify its initiative with signatures from 18 of the state’s districts, while The Idaho Way had to operate under the new law and gather signatures from all 35 districts.

Reclaim Idaho, a campaign behind a ballot initiative for Medicaid expansion, sued over S.B. 1110 in May, and the Idaho Supreme Court ruled Aug. 23 that the new law is unconstitutional, according to an Idaho Statesman report.

In its ruling, the Supreme Court said the law infringed on the public’s right to enact laws outside of the Legislature, and that both the Legislature and the Secretary of State’s Office “failed to present a compelling state interest for limiting that right,” the news outlet reported.

Kind Idaho and The Idaho Way were both watching the case closely.

“Should the decision go in Reclaim’s favor, and the law returns with the 18-district threshold, then we’ll be moving forward with our PAMDA initiative,” Russ Belville, a spokesman for The Idaho Way, told Cannabis Business Times and Cannabis Dispensary earlier this month. “If it doesn’t go in our favor and we’re stuck with 35 districts, we’ll probably fold the PAMDA initiative and put all our efforts into the IMMA medical initiative.”

Winters said Belville had been helping the Kind Idaho campaign prior to launching the PAMDA initiative, and the two groups are continuing to work together as much as possible.

“Everyone working together is how we’re going to get this done,” she said, adding that she is gathering signatures alongside Kind Idaho’s volunteers. “I’m actually out there in my community getting signatures because it’s very important to Idaho and I want to be part of this changing of times, making history in Idaho.”

Filed Under: Cannabis News

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Interim pages omitted …
  • Go to page 115
  • Go to Next Page »

Primary Sidebar

Organizations Submit Comments on CAOA

Oregon Law Enforcement Seizes $50 Million Worth of Cannabis at Illegal Grow

1,335 Pounds of Processed Illegal Cannabis Discovered in California

Zimbabwe Issues 57 Cannabis Cultivation Licenses

Illinois Confesses Licensing Blunder; Has Another Lottery Coming

Panama Legalizes Medical Cannabis: Week in Review

Washington State Reactivates Specific COVID-Related Cannabis Business Allowances

.eco profile for cbdoil.eco